0001209191-24-000461.txt : 20240103
0001209191-24-000461.hdr.sgml : 20240103
20240103171150
ACCESSION NUMBER: 0001209191-24-000461
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240101
FILED AS OF DATE: 20240103
DATE AS OF CHANGE: 20240103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bruno Anthony D
CENTRAL INDEX KEY: 0001374180
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38356
FILM NUMBER: 24508051
MAIL ADDRESS:
STREET 1: C/O WARNER CHILCOTT HOLDINGS CO., LTD.
STREET 2: 100 ENTERPRISE DRIVE
CITY: ROCKAWAY
STATE: NJ
ZIP: 07866
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VYNE Therapeutics Inc.
CENTRAL INDEX KEY: 0001566044
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 453757789
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 685 ROUTE 202/206 N., SUITE 301
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
BUSINESS PHONE: 800-775-7936
MAIL ADDRESS:
STREET 1: 685 ROUTE 202/206 N., SUITE 301
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics Inc.
DATE OF NAME CHANGE: 20180201
FORMER COMPANY:
FORMER CONFORMED NAME: Menlo Therapeutics, Inc.
DATE OF NAME CHANGE: 20170728
FORMER COMPANY:
FORMER CONFORMED NAME: Tigercat Pharma, Inc.
DATE OF NAME CHANGE: 20130104
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-01
0
0001566044
VYNE Therapeutics Inc.
VYNE
0001374180
Bruno Anthony D
C/O VYNE THERAPEUTICS INC.
685 ROUTE 202/206 N, SUITE 301
BRIDGEWATER
NJ
08807
1
0
0
0
0
Stock Option (right to buy)
2.33
2024-01-01
4
A
0
20000
0.00
A
2033-12-31
Common Stock
20000
20000
D
The shares subject to the option vest on January 1, 2025, subject to the Reporting Person's continuous service through such date.
/s/ Mutya Harsch, attorney-in-fact for Anthony D. Bruno
2024-01-03